These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

166 related items for PubMed ID: 6405778

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Dissociation between factor VIII (activity and antigen) and ristocetin-induced platelet aggregation in von Willebrand's disease.
    Barbui T, Dini E.
    Acta Haematol; 1975; 53(1):44-8. PubMed ID: 807074
    [Abstract] [Full Text] [Related]

  • 3. Development of an inhibitor specific to factor VIII: coagulant activity in a patient with platelet-type von Willebrand's disease.
    Castella A, Miller JL, Neuberg RW, Gawryl MS, Hoyer LW.
    Am J Clin Pathol; 1983 Nov; 80(5):745-9. PubMed ID: 6416054
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Defective ristocetin-induced platelet aggregation in von Willebrand's disease and its correction by factor VIII.
    Weiss HJ, Rogers J, Brand H.
    J Clin Invest; 1973 Nov; 52(11):2697-707. PubMed ID: 4201262
    [Abstract] [Full Text] [Related]

  • 6. Diagnosis of von Willebrand's disease. A comparative study of diagnostic tests on nine families with von Willebrand's disease and its differential diagnosis from hemophilia and thrombocytopathy.
    Lian EC, Deykin D.
    Am J Med; 1976 Mar; 60(3):344-56. PubMed ID: 1083143
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. The von Willebrand syndrome.
    Stableforth P, Hughes J, Wilson E, Dormandy KM.
    Br J Haematol; 1975 Apr; 29(4):605-16. PubMed ID: 1081404
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Stabilization of factor VIII in plasma by the von Willebrand factor. Studies on posttransfusion and dissociated factor VIII and in patients with von Willebrand's disease.
    Weiss HJ, Sussman II, Hoyer LW.
    J Clin Invest; 1977 Aug; 60(2):390-404. PubMed ID: 17621
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Infusion of human and canine factor VIII in dogs with von Willebrand's disease: studies of the von Willebrand and factor VIII synthesis stimulating factors.
    Bouma BN, Dodds WJ, van Mourik JA, Sixma JJ, Webster WP.
    Scand J Haematol; 1976 Oct; 17(4):263-75. PubMed ID: 825957
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Studies of the human factor VIII/von Willebrand factor protein. III. Qualitative defects in von Willebrand's disease.
    Gralnick HR, Coller BS, Sultan Y.
    J Clin Invest; 1975 Oct; 56(4):814-27. PubMed ID: 1080491
    [Abstract] [Full Text] [Related]

  • 17. Evaluation of ristocetin-Willebrand factor assay and ristocetin-induced platelet aggregation.
    Olson JD, Brockway WJ, Fass DN, Magnuson MA, Bowie EJ.
    Am J Clin Pathol; 1975 Feb; 63(2):210-8. PubMed ID: 1078748
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Pseudo-von Willebrand's disease. An intrinsic platelet defect with aggregation by unmodified human factor VIII/von Willebrand factor and enhanced adsorption of its high-molecular-weight multimers.
    Weiss HJ, Meyer D, Rabinowitz R, Pietu G, Girma JP, Vicic WJ, Rogers J.
    N Engl J Med; 1982 Feb 11; 306(6):326-33. PubMed ID: 6798442
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.